Does heart rate predict allograft vasculopathy in heart transplant recipients?

Pierre Ambrosi1, Bernard Kreitmann2, Gilbert Habib1

  • 1Department of Cardiology, Hôpital de la Timone, 13385 Marseille, France.

Insights

Resting heart rate does not predict cardiac allograft vasculopathy in heart transplant recipients. This study found no significant difference in coronary lesion development based on heart rate levels after transplantation.

Area of Science:

  • Cardiology
  • Transplantation Immunology
  • Vascular Biology

Background:

  • Atherosclerosis progression is linked to heart rate.
  • Cardiac allograft vasculopathy (CAV) is a major concern post-heart transplantation.
  • Prognostic markers for CAV are crucial for patient management.

Purpose of the Study:

  • To investigate the prognostic value of resting heart rate in predicting CAV development.
  • To assess the association between heart rate and the incidence of coronary lesions after heart transplantation.

Main Methods:

  • Retrospective analysis of 143 heart transplant recipients.
  • Resting heart rate measured 3 months post-transplantation.
  • Coronary angiography performed during a mean follow-up of 9.5 years.

Main Results:

  • No significant difference in survival without coronary lesions between patients with heart rate > or ≤97/min (median).
  • 56 out of 143 patients developed coronary lesions during follow-up.
  • The study did not find a statistically significant correlation between heart rate and CAV.

Conclusions:

  • Resting heart rate measured 3 months post-heart transplantation does not appear to be a significant predictor of cardiac allograft vasculopathy.
  • Further research may be needed to identify other reliable prognostic markers for CAV.

Related Concept Videos